This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paz-Elizur, T. Articles by Livneh, Z. Search for Related Content PubMed PubMed Citation Articles by Paz-Elizur, T. Articles by Livneh, Z.

Reduced Repair of the Oxidative 8-Oxoguanine DNA Damage and Risk of Head and Neck Cancer

¹ Department of Biological Chemistry, Weizmann Institute of Science; ² Hematology Institute and ³ Institute of Oncology, Kaplan Medical Center, Rehovot, Israel; ⁴ Radiotherapy Unit, Division of Oncology, Sourasky Medical Center; ⁵ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; ⁶ The Cancer Research Institute and ⁷ Biostatistics Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel; and ⁸ Department of Industrial Engineering and Management, Ben Gurion University of the Negev, Beer Sheva, Israel

Requests for reprints: Zvi Livneh, Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel. Phone: 972-8-934-3203; Fax: 972-8-934-4169; E-mail: zvi.livneh{at}weizmann.ac.il.

An increasing number of studies indicate that reduced DNA-repair capacity is associated with increased cancer risk. Using a functional assay for the removal of the oxidative DNA lesion 8-oxoguanine by the DNA-repair enzyme 8-oxoguanine DNA glycosylase 1 (OGG1), we have previously shown that reduced OGG activity is a risk factor in lung cancer. Here, we report that OGG activity in peripheral blood mononuclear cells from 37 cases with squamous cell carcinoma of the head and neck (SCCHN) was significantly lower than in 93 control subjects, frequency matched for age and gender. Retesting of OGG activity 3 to 4 years after diagnosis and successful treatment of 18 individuals who recovered from the disease showed that OGG activity values were similar to those determined at diagnosis, suggesting that reduced OGG activity in case patients was not caused by the disease. Logistic regression analysis indicated that the adjusted odds ratio (OR) associated with a unit decrease in OGG activity was statistically significantly increased [OR, 2.3; 95% confidence interval (95% CI), 1.5–3.4]. Individuals in the lowest tertile of OGG activity exhibited an increased risk of SCCHN with an OR of 7.0 (95% CI, 2.0–24.5). The combination of smoking and low OGG was associated with a highly increased estimated relative risk for SCCHN. These results suggest that low OGG is associated with the risk of SCCHN, and if confirmed by additional epidemiologic studies, screening of smokers for low OGG activity might be used as a strategy for the prevention of lung cancer and SCCHN. (Cancer Res 2006; 66(24): 11683-9)

This article has been cited by other articles:

				M. Forsbring, E. S. Vik, B. Dalhus, T. H. Karlsen, A. Bergquist, E. Schrumpf, M. Bjoras, K. M. Boberg, and I. Alseth Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma Carcinogenesis, July 1, 2009; 30(7): 1147 - 1154. [Abstract] [Full Text] [PDF]

				A. Bravard, M. Vacher, E. Moritz, L. Vaslin, J. Hall, B. Epe, and J. P. Radicella Oxidation Status of Human OGG1-S326C Polymorphic Variant Determines Cellular DNA Repair Capacity Cancer Res., April 15, 2009; 69(8): 3642 - 3649. [Abstract] [Full Text] [PDF]

				K. Chen, H. Zhao, Z. Hu, L.-E Wang, W. Zhang, E. M. Sturgis, and Q. Wei CASP3 Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., October 1, 2008; 14(19): 6343 - 6349. [Abstract] [Full Text] [PDF]

				K. Chen, Z. Hu, L.-E Wang, E. M. Sturgis, A. K. El-Naggar, W. Zhang, and Q. Wei Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2007; 28(9): 2008 - 2012. [Abstract] [Full Text] [PDF]